CRP and TNF-α induce PAPP-A expression in human peripheral blood mononuclear cells

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Li, Weiping ^a   Li, Hongwei ^a   Gu, Fusheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; C REACTIVE PROTEIN; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD DONOR; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPERNATANT; WESTERN BLOTTING; DRUG EFFECT; GENETICS; METABOLISM; MONONUCLEAR CELL; TIME;

C-REACTIVE PROTEIN; CELLS, CULTURED; HUMANS; LEUKOCYTES, MONONUCLEAR; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867806201     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/697832     Document Type: Article

References (34)

1. Lawrence J. B., Oxvig C., Overgaard M. T., Sottrup-Jensen L., Gleich G. J., Hays L. G., Yates J. R., Conover C. A., The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 3149 3153 2-s2.0-0032981399 10.1073/pnas.96.6.3149 (Pubitemid 29148859)
2. Ortiz C. O., Chen B. K., Bale L. K., Overgaard M. T., Oxvig C., Conover C. A., Transforming growth factor- β regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. Journal of Bone and Mineral Research 2003 18 6 1066 1072 2-s2.0-0142059642 10.1359/jbmr.2003.18.6.1066 (Pubitemid 37294944)
3. Bayes-Genis A., Schwartz R. S., Lewis D. A., Overgaard M. T., Christiansen M., Oxvig C., Ashai K., Holmes D. R., Conover C. A., Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 3 335 341 2-s2.0-0035097031 (Pubitemid 32199113)
4. Conover C. A., Harrington S. C., Bale L. K., Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Hormone & IGF Research 2008 18 3 213 220 2-s2.0-41649102627 10.1016/j.ghir.2007.09.001 (Pubitemid 351479925)
5. Heeschen C., Dimmeler S., Hamm C. W., Fichtlscherer S., Simoons M. L., Zeiher A. M., Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. Journal of the American College of Cardiology 2005 45 2 229 237 2-s2.0-11844274732 10.1016/j.jacc.2004.09.060 (Pubitemid 40094730)
6. You L., Li L., Zhang F., Xu Q., Ren J., A pilot study of the clinical relevance of the relationship between the serum level of pregnancy-associated plasma protein a and the degree of acute coronary syndrome. The Journal of International Medical Research 2010 38 2 625 632 2-s2.0-77953700628
7. Bayes-Genis A., Conover C. A., Overgaard M. T., Bailey K. R., Christiansen M., Holmes D. R., Virmani R., Oxvig C., Schwartz R. S., Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. The New England Journal of Medicine 2001 345 14 1022 1029 2-s2.0-0035807592 10.1056/NEJMoa003147
8. Boldt H. B., Conover C. A., Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Hormone & IGF Research 2007 17 1 10 18 2-s2.0-33847233874 10.1016/j.ghir.2006.11.003
9. Resch Z. T., Oxvig C., Bale L. K., Conover C. A., Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts. Endocrinology 2006 147 2 885 890 2-s2.0-30944448260 10.1210/en.2005-0908 (Pubitemid 43113006)
10. Harrington S. C., Simari R. D., Conover C. A., Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circulation Research 2007 100 12 1696 1702 2-s2.0-34250795031 10.1161/CIRCRESAHA.106.146183 (Pubitemid 46987861)
11. Resch Z. T., Chen B. K., Bale L. K., Oxvig C., Overgaard M. T., Conover C. A., Pregnancy-associated plasma protein a gene expression as a target of inflammatory cytokines. Endocrinology 2004 145 3 1124 1129 2-s2.0-1442348159 10.1210/en.2003-1313 (Pubitemid 38280991)
12. Li N., Karin M., Is NF-kappaB the sensor of oxidative stress? The FASEB Journal 1999 13 10 1137 1143
13. Lobbes M. B., Kooi M. E., Lutgens E., Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach. International Journal of Vascular Medicine 2010 2010 726207
14. Iversen K. K., Teisner B., Winkel P., Gluud C., Kjoller E., Kolmos H. J., Hildebrandt P. R., Hilden J., Kastrup J., Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Atherosclerosis 2011 214 1 203 208 2-s2.0-78650813352 10.1016/j.atherosclerosis. 2010.10.025
15. Biasillo G., Leo M., della Bona R., Biasucci L. M., Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. Internal and Emergency Medicine 2010 5 3 225 233 2-s2.0-77953539467 10.1007/s11739-010- 0361-1
16. Lund J., Qin Q. P., Ilva T., Pettersson K., Voipio-Pulkki L. M., Porela P., Pulkki K., Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003 108 16 1924 1926 2-s2.0-0142023865 10.1161/01.CIR.0000096054. 18485.07 (Pubitemid 37296534)
17. Mei W. Y., Du Z. M., Zhao Q., Hu C. H., Li Y., Luo C. F., Wu G. F., Chen G. W., Wang L. X., Pregnancy-associated plasma protein predicts outcomes of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome. Heart & Lung: Journal of Acute and Critical Care 2011 40 3 e78 e83 2-s2.0-79955521183 10.1016/j.hrtlng.2010.06.006
18. Lund J., Wittfooth S., Qin Q. P., Ilva T., Porela P., Pulkki K., Pettersson K., Voipio-Pulkki L. M., Free versus total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome. Clinical Chemistry 2010 56 7 1158 1165 2-s2.0-77954353996 10.1373/clinchem.2009.136960
19. Cosin-Sales J., Kaski J. C., Christiansen M., Kaminski P., Oxvig C., Overgaard M. T., Cole D., Holt D. W., Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. European Heart Journal 2005 26 20 2093 2098 2-s2.0-26044452321 10.1093/eurheartj/ehi433 (Pubitemid 41407989)
20. Cosin-Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M. T., Cole D., Holt D. W., Kaski J. C., Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004 109 14 1724 1728 2-s2.0-8444245582 10.1161/01.CIR.0000124716.67921.D2 (Pubitemid 38500673)
21. Rossen M., Iversen K., Teisner A., Teisner B., Kliem A., Grudzinskas G., Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome. Clinical Biochemistry 2007 40 7 478 484 2-s2.0-33947589742 10.1016/j.clinbiochem.2006.11.025 (Pubitemid 46483327)
22. Conover C. A., Chen B. K., Resch Z. T., Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts. Bone 2004 34 2 297 302 2-s2.0-0842265894 10.1016/j.bone.2003.10.011 (Pubitemid 38177611)
23. Filep J. G., Perplexity of monocyte responses to C-reactive protein (CRP). Thrombosis and Haemostasis 2008 99 3 461 462 2-s2.0-42249110893 10.1160TH08-02-0072 (Pubitemid 351549279)
24. Sangiorgi G., Mauriello A., Bonanno E., Oxvig C., Conover C. A., Christiansen M., Trimarchi S., Rampoldi V., Holmes D. R., Schwartz R. S., Spagnoli L. G., Pregnancy-associated plasma protein-A is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques. A link between inflammation and cerebrovascular events. Journal of the American College of Cardiology 2006 47 11 2201 2211 2-s2.0-33646897631 10.1016/j.jacc.2005.11.086 (Pubitemid 43795064)
25. Conover C. A., Harrington S. C., Bale L. K., Oxvig C., Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. American Journal of Physiology 2007 292 2 H994 H1000 2-s2.0-33846999702 10.1152/ajpheart.00798.2006
26. Renier G., Clément I., Desfaits A. C., Lambert A., Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor- α production. Endocrinology 1996 137 11 4611 4618 2-s2.0-0029806068 10.1210/en.137.11.4611 (Pubitemid 26403296)
27. Hirai H., Kanaya R., Maeda M., Qungfang D., Ina K., Hayashi T., The role of insulin growth factor on atherosclerosis and endothelial function: the effect on hyperlipidemia and aging. Life Sciences 2011 88 9-10 425 431 2-s2.0-79951957340 10.1016/j.lfs.2010.12.021
28. Lawrence T., Gilroy D. W., Colville-Nash P. R., Willoughby D. A., Possible new role for NF- κ B in the resolution of inflammation. Nature Medicine 2001 7 12 1291 1297 2-s2.0-0035665020 10.1038/nm1201-1291 (Pubitemid 34007932)
29. Brasier A. R., The nuclear factor-B-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovascular Research 2010 86 2 211 218 2-s2.0-77951674573 10.1093/cvr/cvq076
30. Van Der Heiden K., Cuhlmann S., Luong L. A., Zakkar M., Evans P. C., Role of nuclear factor κ B in cardiovascular health and disease. Clinical Science 2010 118 10 593 605 2-s2.0-77954036224 10.1042/CS20090557
31. Ritchie M. E., Nuclear factor- κ b is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998 98 17 1707 1713 2-s2.0-0032573018 (Pubitemid 28492489)
32. Ahn Y., Kim Y. S., Jeong M. H., The role of nuclear factor kappa B activation in atherosclerosis and ischemic cardiac injury. Korean Circulation Journal 2006 36 4 245 251 2-s2.0-33646472330
33. Bisoendial R. J., Boekholdt S. M., Vergeer M., Stroes E. S. G., Kastelein J. J. P., C-reactive protein is a mediator of cardiovascular disease. European Heart Journal 2010 31 17 2087 2095 2-s2.0-77956398698 10.1093/eurheartj/ehq238
34. Devaraj S., Yun J. M., Adamson G., Galvez J., Jialal I., C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovascular Research 2009 84 3 479 484 2-s2.0-70849095298 10.1093/cvr/cvp249